What Happened?
Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE: USPH) fell 2.1% in the afternoon session after the company reported first-quarter earnings per share that significantly missed analyst expectations.
For its first quarter, U.S. Physical Therapy reported a GAAP loss per share of $0.12, a stark contrast to the analyst consensus of a $0.49 profit. While revenue of $198.3 million was in line with expectations, investors focused on the substantial shortfall in profit. The earnings miss was compounded by an adjusted EBITDA of $20.24 million, which also fell short of the $21.81 million forecast. This significant miss on profitability signaled weaker-than-expected performance, prompting a negative reaction from the market.
The shares were trading at $75.20, down 3.3% from the previous close.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy U.S. Physical Therapy? Access our full analysis report here, it’s free.
What Is The Market Telling Us
U.S. Physical Therapy’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 9 months ago when the stock dropped 11.5% on the news that the company reported third-quarter results that pointed to declining year-over-year profitability, despite revenue beating expectations. The company announced adjusted earnings of $0.66 per share, which was in line with analyst estimates but represented a decrease from the $0.69 per share earned in the same quarter last year. While U.S. Physical Therapy's revenue grew 17.3% year-on-year to $197.1 million, surpassing Wall Street's forecast, the drop in per-share earnings appeared to be the primary concern for investors. The weaker profitability, alongside a slight miss on adjusted EBITDA, overshadowed the strong sales growth, leading to a negative market reaction.
U.S. Physical Therapy is down 4.7% since the beginning of the year, and at $75.20 per share, it is trading 19.3% below its 52-week high of $93.16 from October 2025. Investors who bought $1,000 worth of U.S. Physical Therapy’s shares 5 years ago would now be looking at only $661.01.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
